Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA polymerases (RNAPs) are a diverse group of enzymes responsible for the synthesis of RNA molecules from DNA or RNA templates, a process fundamental to all life and many viral life cycles (Werner & Grohmann, 2011, Nature Reviews Microbiology). In eukaryotic hosts, DNA-directed RNA polymerases (Pol I, II, and III) catalyze the transcription of nuclear DNA into messenger, ribosomal, and transfer RNAs, which are essential for protein synthesis and cellular function (Kuebel et al., 2022, Cells). Many viruses, particularly RNA viruses, encode their own RNA-dependent RNA polymerases (RdRps) to replicate their genomes and transcribe viral mRNA within the host cell (Arnold et al., 2012, Chemical Reviews). Because viral RdRps often lack a direct human homolog, they are highly attractive targets for antiviral therapy, leading to the development of nucleoside and non-nucleoside inhibitors like remdesivir and sofosbuvir (Pruijssers & Denison, 2019, Journal of Biological Chemistry). Conversely, host RNA polymerase inhibitors, such as lurbinectedin, are utilized in oncology to disrupt the rapid transcription required by malignant cells (Kuebel et al., 2022, Cells). However, achieving selectivity for viral polymerases over host polymerases is a significant challenge, as off-target inhibition can lead to mitochondrial toxicity or systemic side effects (Venkatraman et al., 2019, Journal of Medicinal Chemistry). Additionally, the high mutation rate of viral polymerases often leads to the rapid development of drug resistance, necessitating combination therapies (Arnold et al., 2012, Chemical Reviews).
Inhibition of RNA synthesis through nucleoside analog chain termination, competitive binding at the catalytic active site, or allosteric modulation of the enzyme complex to prevent template progression.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral and host RNA polymerases (RNAP).